| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 30 | 2021 | 1988 | 2.870 |
Why?
|
| Polymorphism, Single Nucleotide | 39 | 2022 | 4636 | 1.750 |
Why?
|
| Genetic Predisposition to Disease | 31 | 2024 | 5744 | 1.730 |
Why?
|
| Brain Neoplasms | 26 | 2021 | 4993 | 1.690 |
Why?
|
| Genome-Wide Association Study | 14 | 2024 | 2331 | 1.170 |
Why?
|
| Neurocognitive Disorders | 1 | 2021 | 76 | 0.760 |
Why?
|
| DNA Ligases | 3 | 2010 | 67 | 0.730 |
Why?
|
| DNA Repair | 6 | 2021 | 1912 | 0.720 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2010 | 327 | 0.590 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 1014 | 0.590 |
Why?
|
| Polymorphism, Genetic | 5 | 2021 | 1559 | 0.550 |
Why?
|
| Lung Neoplasms | 12 | 2024 | 12008 | 0.540 |
Why?
|
| Germ-Line Mutation | 4 | 2016 | 1101 | 0.530 |
Why?
|
| Liver Cirrhosis | 4 | 2024 | 1033 | 0.530 |
Why?
|
| Colon | 1 | 2019 | 690 | 0.510 |
Why?
|
| DNA Helicases | 4 | 2011 | 451 | 0.500 |
Why?
|
| DNA-Binding Proteins | 8 | 2023 | 5067 | 0.500 |
Why?
|
| Bacteria | 1 | 2019 | 652 | 0.480 |
Why?
|
| Chromosome Mapping | 4 | 2013 | 1650 | 0.460 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 1159 | 0.460 |
Why?
|
| Genetic Variation | 4 | 2018 | 2155 | 0.460 |
Why?
|
| Haplotypes | 10 | 2012 | 909 | 0.440 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2010 | 550 | 0.440 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 1125 | 0.440 |
Why?
|
| Glioblastoma | 7 | 2017 | 1781 | 0.430 |
Why?
|
| Hepatitis C, Chronic | 2 | 2018 | 469 | 0.420 |
Why?
|
| Exome | 3 | 2016 | 1250 | 0.400 |
Why?
|
| Veterans | 2 | 2023 | 1778 | 0.400 |
Why?
|
| Diet | 1 | 2019 | 1489 | 0.390 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2016 | 417 | 0.370 |
Why?
|
| Hepacivirus | 1 | 2013 | 423 | 0.370 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 445 | 0.370 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2023 | 5601 | 0.360 |
Why?
|
| HMGA2 Protein | 1 | 2010 | 20 | 0.360 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 967 | 0.360 |
Why?
|
| Genotype | 17 | 2017 | 4263 | 0.360 |
Why?
|
| DNA Copy Number Variations | 2 | 2013 | 1555 | 0.340 |
Why?
|
| Cognition Disorders | 1 | 2015 | 771 | 0.340 |
Why?
|
| Genetic Linkage | 3 | 2018 | 601 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 2 | 2023 | 4136 | 0.330 |
Why?
|
| Gamma Rays | 1 | 2010 | 241 | 0.330 |
Why?
|
| Case-Control Studies | 19 | 2023 | 6230 | 0.330 |
Why?
|
| Risk Factors | 20 | 2024 | 18016 | 0.310 |
Why?
|
| Middle Aged | 38 | 2024 | 90349 | 0.300 |
Why?
|
| Adult | 33 | 2021 | 81791 | 0.290 |
Why?
|
| Molecular Epidemiology | 2 | 2018 | 247 | 0.280 |
Why?
|
| Inflammation | 5 | 2018 | 2532 | 0.280 |
Why?
|
| Humans | 62 | 2024 | 271636 | 0.270 |
Why?
|
| Male | 45 | 2024 | 128836 | 0.270 |
Why?
|
| Pedigree | 8 | 2018 | 2034 | 0.260 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 678 | 0.260 |
Why?
|
| DNA Ligase ATP | 3 | 2010 | 53 | 0.250 |
Why?
|
| Female | 45 | 2024 | 148992 | 0.240 |
Why?
|
| Survivors | 1 | 2010 | 1025 | 0.240 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 1173 | 0.240 |
Why?
|
| Telomerase | 2 | 2021 | 542 | 0.230 |
Why?
|
| Lipase | 1 | 2024 | 124 | 0.220 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2024 | 2174 | 0.220 |
Why?
|
| Aged | 20 | 2024 | 73421 | 0.220 |
Why?
|
| Immunogenetics | 1 | 2023 | 18 | 0.220 |
Why?
|
| Mouth Diseases | 1 | 2023 | 38 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5566 | 0.210 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 62 | 0.210 |
Why?
|
| Linkage Disequilibrium | 7 | 2013 | 495 | 0.200 |
Why?
|
| Carrier Proteins | 1 | 2010 | 2138 | 0.190 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2023 | 508 | 0.190 |
Why?
|
| Smoking | 6 | 2024 | 2537 | 0.190 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2668 | 0.190 |
Why?
|
| Calcium-Binding Proteins | 1 | 2023 | 557 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2023 | 1892 | 0.170 |
Why?
|
| Liver Neoplasms | 3 | 2024 | 4805 | 0.160 |
Why?
|
| Neoplasm Grading | 5 | 2017 | 1827 | 0.160 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 1060 | 0.150 |
Why?
|
| Alleles | 7 | 2017 | 2598 | 0.150 |
Why?
|
| Gene Frequency | 5 | 2015 | 1241 | 0.150 |
Why?
|
| ErbB Receptors | 3 | 2011 | 2383 | 0.150 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 604 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 163 | 0.140 |
Why?
|
| Breast Neoplasms | 4 | 2014 | 16226 | 0.140 |
Why?
|
| Microbiota | 1 | 2023 | 544 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 4502 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 10743 | 0.140 |
Why?
|
| Mexican Americans | 1 | 2018 | 334 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 2051 | 0.130 |
Why?
|
| Models, Genetic | 2 | 2012 | 1167 | 0.130 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 361 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2017 | 277 | 0.130 |
Why?
|
| Genetic Association Studies | 6 | 2018 | 1094 | 0.130 |
Why?
|
| Carcinoma, Large Cell | 1 | 2016 | 98 | 0.130 |
Why?
|
| Odds Ratio | 5 | 2015 | 2335 | 0.130 |
Why?
|
| China | 7 | 2011 | 645 | 0.130 |
Why?
|
| Recombinational DNA Repair | 1 | 2015 | 78 | 0.130 |
Why?
|
| Proportional Hazards Models | 3 | 2013 | 5113 | 0.120 |
Why?
|
| Drug Design | 1 | 2017 | 378 | 0.120 |
Why?
|
| Risk | 4 | 2017 | 1950 | 0.120 |
Why?
|
| Young Adult | 12 | 2018 | 22094 | 0.120 |
Why?
|
| Family Health | 2 | 2013 | 348 | 0.120 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 89 | 0.120 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2014 | 179 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2024 | 2973 | 0.110 |
Why?
|
| Computational Biology | 1 | 2019 | 1278 | 0.110 |
Why?
|
| BRCA2 Protein | 1 | 2015 | 379 | 0.110 |
Why?
|
| Penetrance | 1 | 2013 | 134 | 0.110 |
Why?
|
| Risk Assessment | 5 | 2024 | 6876 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2015 | 668 | 0.100 |
Why?
|
| Prognosis | 5 | 2023 | 22525 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 330 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2952 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 15254 | 0.090 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2009 | 85 | 0.090 |
Why?
|
| Family | 1 | 2015 | 778 | 0.090 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2011 | 131 | 0.090 |
Why?
|
| Antigens, Nuclear | 1 | 2011 | 128 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 233 | 0.090 |
Why?
|
| Proteomics | 1 | 2017 | 1436 | 0.090 |
Why?
|
| Decision Trees | 1 | 2010 | 180 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 882 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2023 | 9093 | 0.080 |
Why?
|
| Age Factors | 3 | 2021 | 5509 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2017 | 1206 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2016 | 9467 | 0.080 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 13989 | 0.080 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2009 | 64 | 0.080 |
Why?
|
| Genes, BRCA1 | 1 | 2011 | 398 | 0.080 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2009 | 65 | 0.080 |
Why?
|
| Adolescent | 9 | 2018 | 32609 | 0.080 |
Why?
|
| One-Carbon Group Transferases | 1 | 2008 | 1 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 445 | 0.080 |
Why?
|
| DNA Modification Methylases | 1 | 2009 | 176 | 0.080 |
Why?
|
| Quantitative Trait Loci | 2 | 2022 | 380 | 0.080 |
Why?
|
| Gene Amplification | 1 | 2011 | 770 | 0.080 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 163 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2011 | 580 | 0.080 |
Why?
|
| Endonucleases | 1 | 2009 | 184 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2010 | 221 | 0.070 |
Why?
|
| Pyrenes | 1 | 2007 | 6 | 0.070 |
Why?
|
| DNA Repair Enzymes | 1 | 2009 | 236 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 31032 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 320 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1327 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 231 | 0.070 |
Why?
|
| Astrocytoma | 1 | 2009 | 335 | 0.070 |
Why?
|
| Mutagens | 1 | 2007 | 192 | 0.070 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2007 | 75 | 0.070 |
Why?
|
| Mutation | 3 | 2021 | 15913 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 1443 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 6208 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2009 | 1587 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2007 | 249 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 6266 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 1294 | 0.060 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2024 | 20 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 1588 | 0.060 |
Why?
|
| Phenotype | 1 | 2016 | 6510 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2024 | 13385 | 0.060 |
Why?
|
| Acyltransferases | 1 | 2024 | 67 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2014 | 3670 | 0.060 |
Why?
|
| Genome, Human | 1 | 2011 | 1878 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1597 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 5328 | 0.050 |
Why?
|
| Smokers | 1 | 2024 | 151 | 0.050 |
Why?
|
| Mass Screening | 1 | 2011 | 1547 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2471 | 0.050 |
Why?
|
| Lod Score | 2 | 2012 | 169 | 0.050 |
Why?
|
| Sweden | 2 | 2013 | 86 | 0.050 |
Why?
|
| Denmark | 2 | 2013 | 55 | 0.050 |
Why?
|
| Asthma | 1 | 2010 | 893 | 0.050 |
Why?
|
| Logistic Models | 1 | 2009 | 3460 | 0.050 |
Why?
|
| Lung | 2 | 2023 | 3293 | 0.050 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2021 | 71 | 0.050 |
Why?
|
| United States | 5 | 2024 | 16036 | 0.050 |
Why?
|
| Medical History Taking | 1 | 2021 | 174 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 1884 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 600 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 1719 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2014 | 507 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 2010 | 2649 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 12219 | 0.040 |
Why?
|
| Papillomaviridae | 1 | 2023 | 645 | 0.040 |
Why?
|
| DNA Damage | 1 | 2007 | 1989 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 226 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 2574 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 7971 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 1136 | 0.040 |
Why?
|
| Data Mining | 1 | 2017 | 86 | 0.030 |
Why?
|
| Melanoma | 1 | 2014 | 5591 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 1021 | 0.030 |
Why?
|
| Research Design | 1 | 2024 | 1580 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 380 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 270 | 0.030 |
Why?
|
| Child | 4 | 2013 | 30401 | 0.030 |
Why?
|
| Time Factors | 1 | 2010 | 13116 | 0.030 |
Why?
|
| Prevalence | 2 | 2013 | 3423 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 795 | 0.030 |
Why?
|
| Oligodendroglioma | 1 | 2014 | 106 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 79 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2008 | 5504 | 0.030 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2014 | 131 | 0.030 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2014 | 206 | 0.030 |
Why?
|
| RNA 3' End Processing | 1 | 2013 | 7 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 437 | 0.030 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2013 | 15 | 0.030 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2013 | 56 | 0.030 |
Why?
|
| Israel | 1 | 2013 | 62 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2013 | 130 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 2365 | 0.030 |
Why?
|
| DNA Primers | 1 | 2015 | 1513 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2013 | 291 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 2999 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 239 | 0.020 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2011 | 83 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 659 | 0.020 |
Why?
|
| Ku Autoantigen | 1 | 2011 | 83 | 0.020 |
Why?
|
| Finland | 1 | 2010 | 66 | 0.020 |
Why?
|
| England | 1 | 2010 | 73 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 119 | 0.020 |
Why?
|
| Homozygote | 1 | 2013 | 771 | 0.020 |
Why?
|
| Eczema | 1 | 2010 | 34 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 852 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2011 | 327 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 290 | 0.020 |
Why?
|
| Metabolism | 1 | 2009 | 50 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 1198 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 2009 | 72 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2010 | 33846 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 496 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 5499 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 4391 | 0.020 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2013 | 528 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 2202 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 1482 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2011 | 618 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 6781 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2009 | 267 | 0.020 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2007 | 69 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2010 | 1076 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 660 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2014 | 16943 | 0.020 |
Why?
|
| Biomarkers | 2 | 2009 | 5111 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2007 | 105 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2011 | 520 | 0.020 |
Why?
|
| Meningioma | 1 | 2009 | 307 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 1486 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 371 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 4352 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 39731 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2011 | 1236 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 2495 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 3512 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 636 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2009 | 2150 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 1340 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 3472 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 5856 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 1188 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 2837 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 3223 | 0.010 |
Why?
|
| Carcinoma | 1 | 2011 | 2623 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 10259 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12530 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 13887 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 10354 | 0.010 |
Why?
|